Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1993; Volume 44,Issue 5
  • You have access
    Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine.
    Y J Lin, G J Greif and J E Freedman
    Molecular Pharmacology November 1993, 44 (5) 907-910;
  • You have access
    Cloning and expression of a human Ah receptor cDNA.
    K M Dolwick, J V Schmidt, L A Carver, H I Swanson and C A Bradfield
    Molecular Pharmacology November 1993, 44 (5) 911-917;
  • You have access
    Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
    S R Nash, N Godinot and M G Caron
    Molecular Pharmacology November 1993, 44 (5) 918-925;
  • You have access
    Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
    F Feng, P W Abel, M Scofield, F Liu, D W Wolff and W B Jeffries
    Molecular Pharmacology November 1993, 44 (5) 926-933;
  • You have access
    Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
    C D Funk, L Furci, N Moran and G A Fitzgerald
    Molecular Pharmacology November 1993, 44 (5) 934-939;
  • You have access
    Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
    F Fukamauchi, P A Saunders, C Hough and D M Chuang
    Molecular Pharmacology November 1993, 44 (5) 940-949;
  • You have access
    Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Y Chern, H L Lai, J C Fong and Y Liang
    Molecular Pharmacology November 1993, 44 (5) 950-958;
  • You have access
    Expression of endothelin receptor subtypes in rabbit saphenous vein.
    M L Webb, E C Liu, H Monshizadegan, C C Chao, J Lynch, S M Fisher and P M Rose
    Molecular Pharmacology November 1993, 44 (5) 959-965;
  • You have access
    Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.
    F F Moebius, G G Burrows, M Hanner, E Schmid, J Striessnig and H Glossmann
    Molecular Pharmacology November 1993, 44 (5) 966-971;
  • You have access
    Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram.
    G P Mueller, E J Husten, R E Mains and B A Eipper
    Molecular Pharmacology November 1993, 44 (5) 972-980;
  • You have access
    Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors.
    E Aronica, P Dell'Albani, D F Condorelli, F Nicoletti, N Hack and R Balázs
    Molecular Pharmacology November 1993, 44 (5) 981-989;
  • You have access
    Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain.
    B Schilter and C J Omiecinski
    Molecular Pharmacology November 1993, 44 (5) 990-996;
  • You have access
    Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes.
    S Westin, A Mode, M Murray, R Chen and J A Gustafsson
    Molecular Pharmacology November 1993, 44 (5) 997-1002;
  • You have access
    Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    R W Jansen, D Schols, R Pauwels, E De Clercq and D K Meijer
    Molecular Pharmacology November 1993, 44 (5) 1003-1007;
  • You have access
    Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    L S Melvin, G M Milne, M R Johnson, B Subramaniam, G H Wilken and A C Howlett
    Molecular Pharmacology November 1993, 44 (5) 1008-1015;
  • You have access
    Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
    T Reisine, H Kong, K Raynor, H Yano, J Takeda, K Yasuda and G I Bell
    Molecular Pharmacology November 1993, 44 (5) 1016-1020;
  • You have access
    Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters.
    S W Krauss, R B Ghirnikar, I Diamond and A S Gordon
    Molecular Pharmacology November 1993, 44 (5) 1021-1026;
  • You have access
    Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    P Marcoz, A F Prigent, M Lagarde and G Nemoz
    Molecular Pharmacology November 1993, 44 (5) 1027-1035;
  • You have access
    Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist.
    B Cusack, E Richelson, Y P Pang, J Zaidi and A P Kozikowski
    Molecular Pharmacology November 1993, 44 (5) 1036-1040;
  • You have access
    Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties.
    L Counillon, W Scholz, H J Lang and J Pouysségur
    Molecular Pharmacology November 1993, 44 (5) 1041-1045;
  • You have access
    Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
    R Anand, X Peng, J J Ballesta and J Lindstrom
    Molecular Pharmacology November 1993, 44 (5) 1046-1050;
  • You have access
    Physostigmine block of ion channels activated by acetylcholine in BC3H1 cells.
    R E Wachtel
    Molecular Pharmacology November 1993, 44 (5) 1051-1055;
  • You have access
    The effects of isoflurane on acetylcholine receptor channels.: 2. Currents elicited by rapid perfusion of acetylcholine.
    J P Dilger, R S Brett and H I Mody
    Molecular Pharmacology November 1993, 44 (5) 1056-1063;
  • You have access
    Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
    N R Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas
    Molecular Pharmacology November 1993, 44 (5) 1064-1069;
  • You have access
    N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
    S Wadler, X Mao, R Bajaj, S Hallam and E L Schwartz
    Molecular Pharmacology November 1993, 44 (5) 1070-1076;
  • You have access
    Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
    M Strömstedt, M Warner, C D Banner, P C MacDonald and J A Gustafsson
    Molecular Pharmacology November 1993, 44 (5) 1077-1083;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 44, Issue 5
1 Nov 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics